ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,082,000 | +134.7% | 12,096 | +84.9% | 0.01% | +125.0% |
| Q1 2021 | $887,000 | +25.6% | 6,542 | +18.5% | 0.00% | 0.0% |
| Q4 2020 | $706,000 | +134.6% | 5,519 | +74.5% | 0.00% | +100.0% |
| Q2 2020 | $301,000 | +106.2% | 3,162 | +94.8% | 0.00% | +100.0% |
| Q1 2020 | $146,000 | -99.2% | 1,623 | -99.6% | 0.00% | -98.9% |
| Q1 2019 | $19,404,000 | +43020.0% | 416,666 | +40392.3% | 0.09% | – |
| Q4 2018 | $45,000 | -92.1% | 1,029 | -93.4% | 0.00% | -100.0% |
| Q3 2016 | $568,000 | – | 15,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |